156 related articles for article (PubMed ID: 26871968)
1. Efficacy of a quadruple therapy regimen for Helicobacter pylori eradication after partial gastrectomy.
Zhang F; Bao ZJ; Shi DM; Xiang P; Xiao L; Huang YQ; Zhang GS; Yin SM
Braz J Med Biol Res; 2016 Feb; 49(2):e5080. PubMed ID: 26871968
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of high-dose esomeprazole-amoxicillin dual therapy for Helicobacter pylori rescue treatment: a multicenter, prospective, randomized, controlled trial.
Bi H; Chen X; Chen Y; Zhao X; Wang S; Wang J; Lyu T; Han S; Lin T; Li M; Yuan D; Liu J; Shi Y
Chin Med J (Engl); 2022 Jul; 135(14):1707-1715. PubMed ID: 36193978
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of bismuth quadruple regimens containing tetracycline or furazolidone for initial eradication of Helicobacter pylori.
Wang J; Cao Y; He W; Li X
Medicine (Baltimore); 2021 Dec; 100(51):e28323. PubMed ID: 34941132
[TBL] [Abstract][Full Text] [Related]
4. Doxycycline-based quadruple regimen versus routine quadruple regimen for rescue eradication of Helicobacter pylori: an open-label control study in Chinese patients.
Wang Z; Wu S
Singapore Med J; 2012 Apr; 53(4):273-6. PubMed ID: 22511052
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of two-week therapy with doxycycline-based quadruple regimen versus levofloxacin concomitant regimen for helicobacter pylori infection: a prospective single-center randomized controlled trial.
Alhalabi M; Alassi MW; Alaa Eddin K; Cheha K
BMC Infect Dis; 2021 Jul; 21(1):642. PubMed ID: 34218802
[TBL] [Abstract][Full Text] [Related]
6. Furazolidone-based triple and quadruple eradication therapy for Helicobacter pylori infection.
Xie Y; Zhu Y; Zhou H; Lu ZF; Yang Z; Shu X; Guo XB; Fan HZ; Tang JH; Zeng XP; Wen JB; Li XQ; He XX; Ma JH; Liu DS; Huang CB; Xu NJ; Wang NR; Lu NH
World J Gastroenterol; 2014 Aug; 20(32):11415-21. PubMed ID: 25170230
[TBL] [Abstract][Full Text] [Related]
7. Ten day sequential versus 10 day modified bismuth quadruple therapy as empirical firstline and secondline treatment for Helicobacter pylori in Chinese patients: an open label, randomised, crossover trial.
Liu KS; Hung IF; Seto WK; Tong T; Hsu AS; Lam FY; But DY; Wong SY; Leung WK
Gut; 2014 Sep; 63(9):1410-5. PubMed ID: 24295850
[TBL] [Abstract][Full Text] [Related]
8. Eradication Efficacy of Modified Dual Therapy Compared with Bismuth-Containing Quadruple Therapy as a First-Line Treatment of Helicobacter pylori.
Yang J; Zhang Y; Fan L; Zhu YJ; Wang TY; Wang XW; Chen DF; Lan CH
Am J Gastroenterol; 2019 Mar; 114(3):437-445. PubMed ID: 30807294
[TBL] [Abstract][Full Text] [Related]
9. Furazolidone, amoxicillin, bismuth and rabeprazole quadruple rescue therapy for the eradication of Helicobacter pylori.
Cheng H; Hu FL
World J Gastroenterol; 2009 Feb; 15(7):860-4. PubMed ID: 19230048
[TBL] [Abstract][Full Text] [Related]
10. One-week regimens containing ranitidine bismuth citrate, furazolidone and either amoxicillin or tetracycline effectively eradicate Helicobacter pylori: a multicentre, randomized, double-blind study.
Lu H; Zhang DZ; Hu PJ; Li ZS; Lu XH; Fang XC; Xiao SD
Aliment Pharmacol Ther; 2001 Dec; 15(12):1975-9. PubMed ID: 11736729
[TBL] [Abstract][Full Text] [Related]
11. Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy.
Song Z; Zhou L; Zhang J; He L; Bai P; Xue Y
Dig Liver Dis; 2016 May; 48(5):506-511. PubMed ID: 26847964
[TBL] [Abstract][Full Text] [Related]
12. Furazolidone-containing triple and quadruple eradication therapy for initial treatment for Helicobacter pylori infection: A multicenter randomized controlled trial in China.
Xie Y; Zhang Z; Hong J; Liu W; Lu H; Du Y; Wang W; Xu J; Wang X; Huo L; Zhang G; Lan C; Li X; Li Y; Wang H; Zhang G; Zhu Y; Shu X; Chen Y; Wang J; Lu N;
Helicobacter; 2018 Oct; 23(5):e12496. PubMed ID: 30033619
[TBL] [Abstract][Full Text] [Related]
13. [Effect of furazolidone quadruple regimen plus dental plaque removal procedures as rescue treatment of refractory Helicobacter pylori infection].
Gao W; Hu FL; Wang XM
Zhonghua Yi Xue Za Zhi; 2011 Mar; 91(12):836-9. PubMed ID: 21600165
[TBL] [Abstract][Full Text] [Related]
14. Quadruple therapy with medications containing either rufloxacin or furazolidone as a rescue regimen in the treatment of Helicobacter pylori-infected dyspepsia patients: a randomized pilot study.
Gu LY; Lin WW; Lu H; Chen XY; Ge ZZ; Li XB
Helicobacter; 2011 Aug; 16(4):284-8. PubMed ID: 21762267
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 10 and 14 days of antofloxacin-based versus 14 days of clarithromycin-based bismuth quadruple therapy for Helicobacter pylori eradication: A randomized trial.
He XJ; Wang XL; Huang XY; Li DZ; Liu G; Wang W; Li DL
Clin Res Hepatol Gastroenterol; 2023 Jan; 47(1):102052. PubMed ID: 36400418
[TBL] [Abstract][Full Text] [Related]
16. Vonoprazan on the Eradication of Helicobacter pylori Infection.
Huang J; Lin Y
Turk J Gastroenterol; 2023 Mar; 34(3):221-226. PubMed ID: 36511603
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of furazolidone- and amoxicillin-based quadruple therapy for
Zhang YW; Hu WL; Cai Y; Zheng WF; Du Q; Kim JJ; Kao JY; Dai N; Si JM
World J Gastroenterol; 2018 Oct; 24(40):4596-4605. PubMed ID: 30386109
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of first-line triple therapy with levofloxacin and amoxicillin plus esomeprazole or rabeprazole for the eradication of Helicobacter pylori infection and the effect of CYP2C19 genotype: a 1-week, randomized, open-label study in Chinese adults.
Pan X; Li Y; Qiu Y; Tang Q; Qian B; Yao L; Shi R; Zhang G
Clin Ther; 2010 Nov; 32(12):2003-11. PubMed ID: 21118735
[TBL] [Abstract][Full Text] [Related]
19. Amoxicillin or tetracycline in bismuth-containing quadruple therapy as first-line treatment for
Bang CS; Lim H; Jeong HM; Shin WG; Choi JH; Soh JS; Kang HS; Yang YJ; Hong JT; Shin SP; Suk KT; Lee JJ; Baik GH; Kim DJ
Gut Microbes; 2020 Sep; 11(5):1314-1323. PubMed ID: 32362221
[TBL] [Abstract][Full Text] [Related]
20. Randomized Clinical Trial: Esomeprazole, Bismuth, Levofloxacin, and Amoxicillin or Cefuroxime as First-Line Eradication Regimens for Helicobacter pylori Infection.
Fu W; Song Z; Zhou L; Xue Y; Ding Y; Suo B; Tian X; Wang L
Dig Dis Sci; 2017 Jun; 62(6):1580-1589. PubMed ID: 28391418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]